António Magalhães Cardoso (Senior Partner) writes an article for Kluwer Patent Blog on the Pharma Patent Litigation in Portugal, where he gives his opinion on this complex topic.
“When it comes to the judicial enforcement of pharmaceutical patents in Portugal, over the past few decades the general public has been driven to the misconception that the system protects pharmaceutical industry originators’ tactics to delay the market entry of generics.”
Read the article here.
